Your browser doesn't support javascript.
loading
HHC-induced psychosis: a case series of psychotic illness triggered by a widely available semisynthetic cannabinoid.
O'Mahony, Brian; O'Malley, Andrew; Kerrigan, Olan; McDonald, Colm.
Affiliation
  • O'Mahony B; Department of Psychiatry, University Hospital Galway, Galway, Ireland.
  • O'Malley A; Department of Psychiatry, University Hospital Galway, Galway, Ireland.
  • Kerrigan O; St Michael's Unit, Mercy University Hospital, Cork, Ireland.
  • McDonald C; Department of Psychiatry, University Hospital Galway, Galway, Ireland.
Ir J Psychol Med ; : 1-4, 2024 Feb 14.
Article in En | MEDLINE | ID: mdl-38351841
ABSTRACT
Use of both cannabis and synthetic cannabinoids has been regularly linked to the development of psychotic illness. Thus, semisynthetic cannabinoids such as hexahydrocannabinol (HHC), which have a similar neurobiological profile to delta-9-THC, may also be expected to lead to psychotic illness. However, no such relationship has yet been reported in scientific literature. HHC is readily available online and in many vape shops in Ireland. Here, we present two cases of psychotic illness which appear to have been precipitated by use of legally purchased HHC and discuss its psychotogenic role and factors linked to its current widespread availability.
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Ir J Psychol Med Year: 2024 Document type: Article Affiliation country: Ireland Country of publication: United kingdom

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Ir J Psychol Med Year: 2024 Document type: Article Affiliation country: Ireland Country of publication: United kingdom